-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Zymeworks, Maintains $46 Price Target

Benzinga·06/03/2026 11:03:55
Listen to the news
HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Buy and maintains $46 price target.